Curator's Take
This article spotlights chemistry as the most realistic near‑term arena for a quantum computing breakthrough, echoing recent demonstrations that quantum processors can now estimate small molecule energies with chemical accuracy. By linking those technical advances to drug discovery pipelines, it frames a clear commercial pathway that could justify early-stage venture funding and accelerate real‑world impact. The authors also temper optimism with the reminder that scaling hardware and error mitigation remain critical hurdles before routine pharmaceutical simulations become routine.
— Mark Eatherly
Summary
By Dr. Kris Naudts, Zeynep Koruturk and Donald Harmitt @ Firgun Ventures. Firgun Ventures is a VC firm investing in Series A/B quantum scale-ups globally. Among the futures promised for quantum computing, chemistry has the strongest claim to arriving first, and being the most direct line to human health. Bringing a new drug to market […]